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Synthesis and characterization of some novel 1,2,4-triazoles, 
1,3,4-thiadiazoles and Schiff  bases incorporating imidazole 
moiety as potential antimicrobial agents
(1,4,5-Triphenylimidazol-2-yl-thio)butyric acid hydrazide 
(3) was obtained via alkylation of 1,4,5-triphenylimidazol-2-
thiol (1) with ethylbromobutyrate, followed by addition of 
hydrazine hydrate. Treatment of acid hydrazide 3 with car-
bon disulfi de in an ethanolic potassium hydroxide solution 
gave the intermediate potassium dithiocarbazinate salt, 
which was cyclized to 4-amino-5-[(1,4,5-triphenylimidazol-
-2-yl)thiopropyl]-2H-1,2,4-triazole-3-thione (4) in the pres-
ence of hydrazine hydrate. Condensation of compound 3 
with alkyl/arylisothiocyanate aff orded the corresponding 
1-[4-(1,4,5-triphenylimidazol-2-ylthio)butanoyl]-4-alkyl/ar-
ylthiosemicarbazides (5–7), which upon refl uxing with so-
dium hydroxide, yielded the corresponding 1,2,4-triazole - 
-3-thiols 8–10. Under acidic conditions, compounds 4–6 
were converted to aminothiadiazoles 11–13. Moreover, the 
series of Schiff  bases 14–18 were synthesized from the con-
densation of compound 3 with diff erent aromatic alde-
hydes. The newly synthesized compounds were character-
ized by IR, 1H NMR, 13C NMR and mass spectral analyses. 
They were also preliminarily screened for their antimicro-
bial activity.
Keywords: imidazole, 1,2,4-triazole, 1,3,4-thiadiazole, Schiff  
bases, antimicrobial activity
Imidazole nucleus has emerged as an important class of azoles used in various ap-
plications. In addition, thioimidazole nucleus constitutes the active part of several bio-
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Literature survey reveals that several 1,2,4-triazole derivatives have been investigated 
as therapeutically interesting compounds due to the large diversity of their eff ects, such as 
anticonvulsant (3), antimicrobial (4), analgesic (5), antioxidant (6), anti-infl ammatory (7), 
pesticidal (8), insecticidal (9), herbicidal (10) and fungicidal ones (11).
Compounds bearing 1,3,4-thiadiazole moieties have displayed a number of chemo-
therapeutic properties including antibacterial (12), antifungal (13), antitubercular (14) and 
analgesic ones (15). On the other hand, Schiff  bases are considered privileged structures in 
drug discovery, with signifi cant antimicrobial, antiviral, antifungal, antibacterial and 
anti-infl ammatory (16–20) activities as well as chelating properties towards various metal 
ions (21).
Prompted by these observations and in continuation of our search on the synthesis of 
heterocyclic compounds containing nitrogen, sulfur and bicyclic systems with potential 
biological activity (22–24), we have designed the synthesis of a novel series of imidazole 
derivatives. In particular, we emphasized the strategy of combining chemically diff erent 
but pharmacologically compatible molecules (the imidazole nucleus and the 1,2,4-triazole, 




Melting points were determined on a variable heater (Stuart, UK) Melt-temp appara-
tus and are uncorrected. Percoated silica gel (Kieselgel, 0.25 mm, 60 F254, Merck, Germa-
ny) were used for thin layer chromatography. A developing solvent system of ethyl acetate/
hexane (1/2) was used and the spots were detected by ultraviolet light. NMR spectra were 
measured with a Bruker 400 MHz (13C: 100 MHz) spectrometer (Bruker, Switzerland). 
Chemical shi s are expressed in d-values (ppm) relative to TMS as an internal standard, 
using DMSO-d6 as a solvent. The IR spectra were measured in potassium bromide pellets 
using a Perkin-Elmer 1430 series FTIR spectrometer (Perkin-Elmer, USA). Full scan accu-
rate mass spectra (mass range from 200 to 1500 Da) were obtained at high resolution 
[100,000, full-width half-maximum (FWHM) at 400 m/z] on a LTQ-FT Orbitrap Velos mass 
spectrometer (Thermo Electron GmbH, Germany). The hybrid mass spectrometer was 
equipped with a heated electrospray ionization (ESI) probe for the ion max source and 
operated in the positive mode. The electrospray source conditions were: capillary voltage 
3.75 kV, heated capillary temperature 275 °C, source temperature 450 °C and S-Lens RF 
level 60 %. Nitrogen gas fl ows were set at 40 for the sheath gas and at 20 for the auxiliary 
gas, in arbitrary units. Elemental analyses were performed using an elementar Analysen-
systeme GmbH-Vario EL III Element Analyzer (Germany).
Syntheses
Ethyl(1,4,5-triphenylimidazol-2-yl)thiobutyrate (2). – To a solution of compound 1 (3.281 g, 
10 mmol) in DMF (15 mL), NaH (10 mmol) was added, followed by the addition of ethyl-
bromobutyrate (1.506 g, 10 mmol). The mixture was heated under refl ux for 8 h, then 
cooled and poured onto crushed ice. The product was collected by fi ltration, washed with 
water, dried and recrystallized from ethanol.
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(1,4,5-Triphenylimidazol-2-ylthio)butyric acid hydrazide (3). – A mixture of compound 2 
(4.425 g, 10 mmol) and hydrazine hydrate (10 mmol) in ethanol (25 mL) was refl uxed for 
10 h. A er cooling to room temperature, ethanol was removed under reduced pressure, 
and the product was recrystallized from ethanol.
4-Amino-5-[(1,4,5-triphenylimidazol-2-yl)thiopropyl]-2H-1,2,4-triazole-3-thione (4). – Car-
bon disulfi de (1.14 g, 15 mmol) was added dropwise to a solution of compound 3 (4.281 g, 
10 mmol) in absolute ethanol (30 mL) containing potassium hydroxide (0.84 g, 15 mmol) at 
0 °C. The reaction mixture was stirred at room temperature for 16 h, and then cooled and 
diluted with diethyl ether. The precipitate was fi ltered, washed with diethyl ether and 
dried. The potassium dithiocarbazinate salt was obtained in nearly quantitative yield and 
was used without further purifi cation since it was moisture sensitive.
Hydrazine hydrate (20 mmol) was added to a suspension of the potassium salt of di-
thiocarbazinate (10 mmol) in water (10 mL) and the mixture was refl uxed with stirring for 
4 h. A er cooling, it was diluted with water, then acidifi ed with aqueous hydrochloric acid. 
The precipitate was fi ltered, washed with water and recrystallized from ethanol to give 
yellow needles.
1-[4-(1,4,5-Triphenylimidazol-2-ylthio)butanoyl]-4-phenylthiosemicarbazides (5–7). General 
method. – A mixture of compound 3 (4.281 g, 10 mmol) and the appropriate isothiocyanate 
derivative (10 mmol) was refl uxed in ethanol for 6 h. The solution was cooled and a white 
solid appeared. The obtained precipitate was fi ltered and recrystallized from ethanol to 
aff ord the desired product.
4-Alkyl/aryl-5-[(1,4,5-triphenylimidazol-2-yl)thiopropyl]-2H-1,2,4-triazole-3-thione (8–10). 
General method. – A solution of the corresponding thiosemicarbazide 5–7 (10 mmol) in 100 mL 
of 4 mol L–1 NaOH was refl uxed for 8 h. The resulting solution was cooled to room tem-
perature and acidifi ed with 37 % HCl. The precipitate formed was fi ltered, washed with 
water and recrystallized from ethanol to aff ord the desired product.
5-[(1,4,5-Triphenylimidazol-2-yl)thiopropyl]-2-(N-alkyl/arylamino)-1,3,4-thiadiazoles (11–13). 
General method. – A mixture of the corresponding thiosemicarbazide 5–7 (10 mmol) in cold 
concentrated sulfuric acid (20 mL) was stirred for 30 min. The mixture was then allowed 
to cool to room temperature. A er stirring for additional 3 h, the resulting solution was 
poured into ice-cold water and made alkaline to pH 8 with ammonia. The precipitated 
product was fi ltered and recrystallized from ethanol to aff ord the desired product.
4-[(1,4,5-Triphenylimidazol-2-yl)thio]-N’-(arylidene)-butanehydrazides (14–18). General meth-
od. – A mixture of compound 3 (0.428 g, 1 mmol) and the appropriate aromatic aldehyde (1 
mmol) in ethanol (20 mL) and (0.5 mL) of HCl (37 %) was refl uxed for 4–6 h. A er cooling, 
the obtained product was collected and recrystallized from ethanol.
Physical, analytical data and spectral data (MS, IR, 1H- and 13C-) for the newly synthe-
sized products 2–18 are collected in Tables I and II. Elemental analyses of all compounds 
were within ± 0.4 % of the theoretical values.
Antimicrobial susceptibility testing
The clinical isolate tested in this study were obtained from the culture collection 
maintained at the RCMB (Regional Center for Mycology and Biotechnology/Antimicrobial 
unit test organisms), Al Azhar University, Cairo-Egypt. All compounds were tested in vitro 
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Exp. MS : [M+H]+
Calcd./found (%)
C H N
  2 115–116(85)
443.18
443.18 73.27/73.03 5.92/5.69 6.33/6.23
  3 169–170(82)
429.18
429.18 70.07/69.84 5.64/5.35 13.07/13.19
  4 263–264(77)
485.18
485.18 64.43/64.25 4.99/5.16 17.34/17.13
  5 238–239(90)
564.19
564.19 68.18/67.99 5.19/5.01 12.42/12.30
  6 190–191(83)
516.19
516.19 65.21/65.47 5.67/5.39 13.58/13.34
  7 222–223(80)
502.17
502.17 64.64/64.97 5.42/5.14 13.96/13.71
  8 261–262(84)
546.18
546.18 70.43/70.31 4.99/5.12 12.83/12.56
  9 233–234(79)
498.18
498.18 67.57/67.42 5.47/5.26 14.07/13.76
10 250–251(82)
484.16
484.16 67.05/66.79 5.21/5.49 14.48/14.76
11 279–280(74)
546.18
546.18 70.43/70.17 4.99/5.29 12.83/12.99
12 247–248(70)
498.18
498.18 67.57/67.91 5.47/5.70 14.07/14.38
13 262–263(73)
484.16
484.16 67.05/67.29 5.21/5.44 14.48/14.16
14 225–226(87)
533.20
533.20 72.16/72.45 5.30/5.19 10.52/10.21
15 196–197(85)
551.17
551.17 69.74 /69.39 4.94/5.24 10.17/10.26
16 179–180(90)
551.17
551.16 69.74/69.95 4.94/5.09 10.17/10.38
17 220–221(82)
595.11
595.11 64.54/64.87 4.57/4.74 9.41/9.65
18 245–246(86)
595.12
595.11 64.54/64.78 4.57/4.67 9.41/9.76
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Table II. IR, 1H-, and 13C NMR spectral data for the newly synthesized compounds 2–18
Compd. IR (KBr, νmax, cm–1) 1H NMR (d, ppm) 13C NMR (d, ppm)
  2 1740 (C=O), 1637 
(C=N), 1205 (C-O)
1.95–1.98 (quin, 2H, 
CH2CH2CH2), 2.41 (t, 2H, 
CH2CO), 3.16 (t, 2H, SCH2), 
4.02–4.05 (q, 2H, OCH2), 
7.15–7.45 (m, 15H, H-Ar)
14.09 (CH2CH3), 24.61 
(CH2CH2CH2), 31.72 (CH2CO), 32.22 
(SCH2), 59.88 (OCH2), 126.19, 126.5, 
128.17, 128.28, 128.35, 128.92, 129.13, 
130.12, 130.72, 131.04, 134.17, 135.36, 
137.35, 142.35 (C-Ar, C=N)
  3 3256–3380 (NH, 
NH2), 1692 (C=O), 
1630 (C=N)
1.91–1.96 (quin, 2H, 
CH2CH2CH2), 2.14 (t, 2H, 
CH2CO), 3.14 (t, 2H, SCH2), 
4.16 (s, 2H, NH2), 7.12–7.44 
(m, 15H, H-Ar), 9.00 (s, 1H, 
NH)
25.33 (CH2CH2CH2), 32.01 (CH2CO), 
32.25 (SCH2), 126.22, 126.47, 128.16, 
128.28, 128.32, 128.51, 128.90, 129.13, 
130.13, 130.73, 130.98, 134.18, 135.37, 
137.33, 142.51 (C-Ar, C=N), 170.89 
(C=O)
  4 3240–3367 (NH, 
NH2), 1643 (C=N), 
1290 (C=S)
2.04–2.11 (quin, 2H, 
CH2CH2CH2), 2.82 (t, 2H, 
CH2C=N), 3.27 (t, 2H, SCH2), 
5.76 (s, 2H, NH2), 7.22–7.46 (m, 
15H, H-Ar), 14.40 (s, 1H, NH)
23.58 (CH2CH2CH2), 25.10 
(CH2C=N), 32.11 (SCH2), 126.80, 
126.91, 127.54, 128.22, 128.42, 128.59, 
128.91, 129.24, 129.53, 130.76, 131.57, 
131.57, 134.57, 141.90, 142.08, 163.38 
(C-Ar, C=N), 177.64 (C=S)
  5 3210–3352 (NH), 
1670 (C=O), 1642 
(C=N), 1302 (C=S)
1.96–2.03 (quin, 2H, 
CH2CH2CH2), 2.32 (t, 2H, 
CH2CO), 3.21 (t, 2H, SCH2), 
7.12–7.47 (m, 20H, H-Ar), 9.57 
(d, 1H, NH), 9.62 (s, 1H, NH), 
9.90 (d, 1H, NH)
24.64 (CH2CH2CH2), 31.95 (CH2CO), 
32.12 (SCH2), 126.20, 126.45, 128.13, 
128.24, 128.30, 128.49, 128.89, 129.12, 
130.06, 130.68, 130.95, 134.13, 135.31, 
137.31, 142.49 (C-Ar, C=N), 173.66 
(C=O)
  6 3240–3367 (NH), 
1689 (C=O), 1634 
(C=N), 1290 (C=S)
1.03 (t, 3H, CH2CH3), 1.91–1.98 
(quin, 2H, CH2CH2CH2), 2.27 
(t, 2H, CH2CO), 3.18 (t, 2H, 
SCH2), 3.36–3.42 (m, 2H, 
NCH2), 7.16–7.45 (m, 15H, 
H-Ar), 7.91 (t, 1H, NH), 9.06 
(d, 1H, NH), 9.65 (s, 1H, NH)
14.45 (CH2CH3), 24.60 
(CH2CH2CH2), 31.92 (CH2CO), 32.03 
(SCH2), 38.35 (NCH2), 126.19, 126.45, 
128.13, 128.23, 128.31, 128.49, 128.90, 
129.12, 130.05, 130.68, 130.95, 134.11, 
135.31, 137.30, 142.48 (C-Ar, C=N), 
171.31 (C=O)
  7 3234–3380 (NH), 
1663 (C=O), 1650 
(C=N), 1303 (C=S)
1.92–1.99 (quin, 2H, 
CH2CH2CH2), 2.27 (t, 2H, 
CH2CO), 2.84 (d, 3H, NCH3), 
3.18 (t, 2H, SCH2), 7.14–7.45 (m, 
15H, H-Ar), 7.88 (d, 1H, NH), 
9.12 (d, 1H, NH), 9.67 (s, 1H, 
NH)
24.55 (CH2CH2CH2), 30.81 (NCH3), 
31.91 (CH2CO), 32.01 (SCH2), 126.20, 
126.46, 128.14, 128.24, 128.30, 128.50, 
128.90, 129.13, 130.04, 130.67, 130.95, 
134.11, 135.30, 137.30, 142.49 (C -Ar, 
C=N), 171.37 (C=O)
  8 3224–3290 (NH), 
1697 (C=N), 1282 
(C=S)
1.92–1.99 (quin, 2H, 
CH2CH2CH2), 2.53 (t, 2H, 
CH2C=N), 3.12 (t, 2H, SCH2), 
7.14–7.52 (m, 20H, H-Ar), 13.74 
(s, 1H, NH)
24.03 (CH2CH2CH2), 25.19 
(CH2C=N), 31.34 (SCH2), 126.15, 
126.43, 128.15, 128.22, 128.30, 128.50, 
128.85, 129.07, 129.34, 130.04, 130.94, 
133.64, 134.07, 135.25, 137.29, 142.13, 
151.54, 167.65 (C-Ar, C=N)
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Compd. IR (KBr, νmax, cm–1) 1H NMR (d, ppm) 13C NMR (d, ppm)
  9 3265–3305 (NH), 
1694 (C=N), 1305 
(C=S)
1.15 (t, 3H, CH2CH3), 2.08–2.15 
(quin, 2H, CH2CH2CH2), 2.80 
(t, 2H, CH2C=N), 3.27 (t, 2H, 
SCH2), 3.89–3.94 (q, 2H, NCH2), 
7.17–7.43 (m, 15H, H-Ar), 13.56 
(s, 1H, NH)
13.37 (CH2CH3), 23.27 
(CH2CH2CH2), 25.56 (CH2C=N), 
31.90 (SCH2), 48.56 (NCH2), 126.36, 
126.82, 128.23, 128.53, 129.13, 129.56, 
130.60, 130.71, 131.23, 131.76, 134.08, 
135.66, 138.12, 142.09, 151.90, 166.58 
(C- Ar, C=N)
10 3220–3279 (NH), 
1642 (C=N), 1295 
(C=S)     
2.07–2.14 (quin, 2H, 
CH2CH2CH2), 2.50 (s, 3H, 
NCH3), 2.78 (t, 2H, CH2C=N), 
3.21 (t, 2H, SCH2), 7.14–7.45 (m, 
15H, H-Ar), 13.52 (s, 1H, NH)
23.60 (CH2CH2CH2), 25.16 (NCH3), 
29.62 (CH2C=N), 31.53 (SCH2), 
126.10, 126.44, 128.18, 128.33, 128.50, 
128.67, 129.09, 130.04, 130.69, 131.03, 
134.05, 135.29, 137.28, 142.20, 151.90, 
166.58 (C-Ar, C=N)
11 3254–3298 (NH), 
1634 (C=N)
2.03–2.11 (quin, 2H, 
CH2CH2CH2), 2.99 (t, 2H, 
CH2C=N), 3.24 (t, 2H, SCH2), 
7.21–7.59 (m, 20H, H-Ar), 10.48 
(s, 1H, NH)
27.81 (CH2CH2CH2), 28.70 
(CH2C=N), 33.11 (SCH2), 116.22, 
125.86, 126.56, 126.85, 127.23, 128.23, 
128.69, 129.36, 130.04, 130.73, 132.30, 
134.03, 140.68, 141.50, 141.96, 147.98, 
158.75, 164.02 (C-Ar, C=N)
12 3213–3296 (NH), 
1637 (C=N)
1.20 (t, 3H, CH2CH3), 2.04–2.11 
(quin, 2H, CH2CH2CH2), 2.97 
(t, 2H, CH2C=N), 3.24 (t, 2H, 
SCH2), 3.33–3.42 (q, 2H, 
NCH2), 7.19–7.54 (m, 15H, 
H-Ar), 9.96 (s, 1H, NH)
13.34 (CH2CH3), 27.78 
(CH2CH2CH2), 28.16 (CH2C=N), 
32.17 (SCH2), 40.83 (NCH2), 125.96, 
126.33, 128.23, 128.64, 129.01, 129.30, 
129.65, 130.65, 131.03, 131.93, 134.33, 
142.11, 147.28, 157.74, 167.74 (C-Ar, 
C=N)
13 3207–3231 (NH), 
1641 (C=N)
2.05–2.12 (quin, 2H, 
CH2CH2CH2), 2.96–2.99 (m, 
5H, CH2C=N, NCH3), 3.24 (t, 
2H, SCH2), 7.19–7.53 (m, 15H, 
H-Ar), 9.90 (s, 1H, NH)
27.79 (CH2CH2CH2), 28.17 
(CH2C=N), 32.07 (SCH2), 38.83 
(NCH3), 125.67, 126.25, 128.23, 
128.64, 128.97, 129.29, 129.62, 130.64, 
131.22, 131.88, 134.52, 142.23, 146.77, 
157.85, 168.75 (C- Ar, C=N)
14 3254–3342 (NH), 
1704 (C=O), 1672 
(C=N)
1.95–2.03 (quin, 2H, 
CH2CH2CH2), 2.36 (t, 0.8H, 
CH2CO), 2.76 (t, 1.2H, CH2CO), 
3.17–3.23 (m, 2H, SCH2), 
7.14–8.07 (m, 20H, H-Ar, OH), 
8.10 (s, 0.25H, H-C=N), 8.31 (s, 
0.25H, H-C=N), 8.49 (s, 0.15H, 
H-C=N), 8.70 (s, 0.4H, H-C=N), 
11.37 (s, 0.35H, CONH), 11.49 
(s, 0.25H, CONH), 11.54 (s, 
0.25H, CONH), 11.67 (s, 0.15H, 
CONH)
24.24, 24.89 (CH2CH2CH2), 30.56, 
31.76 (CH2CO), 31.88, 32.09 (SCH2), 
122.17, 123.11, 125.70, 126.13, 126.17, 
126.41, 127.26, 128.10, 128.46, 128.84, 
129.07, 130.65, 130.92, 131.13, 132.94, 
134.11, 135.35, 135.96, 137.29, 140.88, 
144.04, 160.56 (C- Ar, C=N), 168.18, 
173.82 (C=O)
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for their antibacterial activity against the following clinical bacterial strains: Gram nega-
tive bacteria, Escherichia coli (RCMB 0100520, Pseudomonas aeruginosa (RCMB 010043), and 
Gram positive bacteria, Streptococcus pneumonia (RCMB 010010), Bacillus subtilis (RCMB 
010067) by the agar diff usion method (25) using Müller-Hinton agar medium for bacteria. 
Antimicrobial susceptibility testing was performed by the agar disc-diff usion meth-
od. Sterile fi lter paper discs (8 mm diameter) were moistened with the compound solution 
in dimethylsulphoxide of specifi c concentration. Forty µL of the solution containing 200 
µg of test compound or reference drug (gentamicin or ampicillin trihydrate) was loaded 
onto fi lter paper discs. Solvent was evaporated and discs were transferred to the inocu-
Compd. IR (KBr, νmax, cm–1) 1H NMR (d, ppm) 13C NMR (d, ppm)
15 3260–3322 (NH), 
1698 (C=O), 1645 
(C=N)
1.99–2.07 (quin, 2H, 
CH2CH2CH2), 2.39 (t, 0.8H, 
CH2CO), 2.72 (t, 1.2H, CH2CO), 
3.17–3.26 (m, 2H, SCH2), 
6.80–7.46 (m, 19H, H-Ar), 8.26 
(s, 0.40H, H-C=N), 8.34 (s, 
0.60H, H-C=N), 11.30 (s, 0.60H, 
CONH), 11.67 (s, 0.40H, 
CONH)
24.21, 24.55 (CH2CH2CH2), 30.58, 
31.91 (CH2CO), 32.35, 32.51 (SCH2), 
116.06, 116.29, 118.15, 118.56, 119.20, 
119.59, 126.41. 126.58, 126.88, 128.50, 
129.13, 129.55, 130.80, 131.14, 133.23, 
135.05, 136.49, 140.77, 142.38, 156.31, 
158.60 (C-Ar, C=N), 167.74, 172.75 
(C=O)
16 3275–3330 (NH), 
1690 (C=O), 1640 
(C=N)
1.99–2.02 (quin, 2H, 
CH2CH2CH2), 2.38 (t, 0.8H, 
CH2CO), 2.73 (t, 1.2H, CH2CO), 
3.19, 3.21 (2t, 2H, SCH2), 
7.13–7.93 (m, 19H, H-Ar), 8.11 
(s, 0.40H, H-C=N), 8.72 (s, 
0.60H, H-C=N), 11.38 (s, 0.60H, 
CONH), 11.56 (s, 0.40H, CONH)
24.26 (CH2CH2CH2), 30.86, 31.90 
(CH2CO), 31.88, 32.10 (SCH2), 126.13, 
126.90, 127.83, 128.09, 128.21, 128.46, 
129.05, 130.65, 130.89, 131.16, 134.10, 
137.29, 142.34, 160.56 (C-Ar, C=N), 
160.61, 173.84 (C=O)
17 3206–3287 (NH), 
1700 (C=O), 1692 
(C=N)         
1.99–2.04 (quin, 2H, 
CH2CH2CH2), 2.37 (t, 0.8H, 
CH2CO), 2.76 (t, 1.2H, CH2CO), 
3.18–3.25 (m, 2H, SCH2), 
7.16–8.50 (m, 19H, H-Ar), 8.71 
(s, 0.40H, H-C=N), 8.90 (s, 
0.60H, H-C=N), 11.39 (s, 0.60H, 
CONH), 11.77 (s, 0.40H, 
CONH)
24.28, 24.89 (CH2CH2CH2), 30.55, 
30.65 (CH2CO), 32.12, 32.22 (SCH2), 
125.51, 126.03, 126.63, 128.12, 128.21, 
128.74, 130.40, 130.66, 131.23, 132.27, 
132.58, 133.13, 133.63, 133.93, 134.16, 
140.71, 143.89, 159.68, 160.53 (C -Ar, 
C=N), 161.87, 167.34 (C=O)
18 3206–3287 (NH), 
1700 (C=O), 1692 
(C=N)
2.00–2.04 (quin, 2H, 
CH2CH2CH2), 2.30 (t, 0.8H, 
CH2CO), 2.78 (t, 1.2H, CH2CO), 
3.11–3.23 (m, 2H, SCH2), 
7.14–7.89 (m, 19H, H-Ar), 8.31 
(s, 0.60H, H-C=N), 8.49 (s, 
0.40H, H-C=N), 11.50 (s, 0.60H, 
CONH), 11.62 (s, 0.40H, 
CONH)
24.29, 24.85 (CH2CH2CH2), 30.68, 
31.90 (CH2CO), 32.06, 32.86 (SCH2), 
123.12, 123.36, 126.14, 126.18, 126.90, 
127.96, 128.10, 128.24, 128.82, 129.05, 
130.08, 130.91, 131.27, 131.55, 132.96, 
133.08, 134.12, 135.35, 140.92, 142.41, 
142.46, 144.06 (C -Ar, C=N), 168.13, 
173.83 (C=O)
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lated plates. Loaded discs were carefully placed on Müller-Hinton for bacteria and Sab-
ouraud’s agar for fungi, previously inoculated separately with the test microorganisms. 
The plates were incubated at 37 oC for bacteria and 28 oC for fungi, diameters of the growth 
inhibition zones were measured a er 24 hours in case of bacteria and a er 48–96 hours in 
case of fungi. The antimicrobial activity was evaluated by measuring the zone of inhibi-
tion against the tested organisms and compared with that of the standards. Antimicrobial 
activities were expressed as the inhibition diameter zones in millimeters (mm) and are 
presented in Tables III and IV. Each experiment was carried out in triplicate and the aver-
age zone of inhibition was calculated.
Moreover, compounds 2–18 were also subjected to in vitro testing of antifungal activ-
ity against the following four clinical fungal strains: Aspergillus fumigatus (RCMB 02568), 
Syncephalastrum racemosum (RCMB 05922), Geotrichum candidum (RCMB 05097), and Can-
dida albicans (RCMB 05031) by agar diff usion method (26) using Sabouraud’s agar medium 
for fungi.
Table III. Antibacterial activity of compounds 2–18 against Gram negative and Gram positive bacteria
Compound
Mean value of inhibition zone diameter (mm)
Gram positive bacteria Gram negative bacteria
S. pneumoniae B. subtilis P. aeruginosa E. coli
  2 13.0 15.3 NA 12.3
  3 13.9 16.0 NA 13.2
  4 19.4 24.6 NA 16.3
  5 19.8 22.4 NA 14.2
  6 17.2 18.3 NA 13.7
  7 12.3 14.2 NA NA
  8 19.4 21.3 NA 12.7
  9 18.1 19.6 NA 11.9
10 10.3 12.4 NA NA
11 19.1 20.8 NA 14.9
12 17.3 18.7 NA 11.0
13 17.9 19.0 NA 12.7
14 20.6 25.4 NA 17.2
15 14.4 18.2 NA 13.9
16 13.8 16.5 NA 10.2
17 18.2 19.4 NA 15.6
18 13.7 15.0 NA 10.4
Ampicillin 20.8 26.7 – –
Gentamicin – – 16.1 18.3
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Table IV. Antifungal activity of compounds 1–7 against some fungi
Compound
Mean value of inhibition zone diameter (mm)
A. fumigatus S. racemosum G. candidum C. albicans
  2 14.3 NA 16.1 13.6
  3 14.9 NA 16.8 14.2
  4 19.3 NA 23.3 18.3
  5 18.6 NA 20.6 18.7
  6 16.7 NA 17.8 15.1
  7 NA NA NA NA
  8 17.4 NA 18.3 16.4
  9 16.8 NA 18.3 15.9
10 NA NA NA NA
11 19.4 NA 20.6 18.2
12 15.2 NA 16.4 15.8
13 15.6 NA 17.8 16.3
14 20.1 NA 25.8 21.6
15 19.3 NA 20.3 18.3
16 13.2 NA 14.3 11.1
17 17.8 NA 15.8 14.7
18 13.9 NA 16.2 13.4
Amphotericin B 20.4 17.3 26.3 22.0
Scheme 1
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Synthesis of the title azole compounds required stepwise reactions starting from 
1,4,5-triphenylimidazole-2-thiol (1), as illustrated in Schemes 1–3. The starting compound 
1 was prepared according to the literature (27).
Alkylation of compound 1 with 4-ethylbromobutyrate in dimethylformamide in the 
presence of sodium hydride as a base gave ethyl(1,4,5-triphenylimidazol-2-yl)thiobutyrate 
(2) in 85 % yield. Hydrazinolysis of ester 2 with an equimolar amount of hydrazine hydrate 
furnished the corresponding acid hydrazide 3 (Scheme 1).
All the newly synthesized compounds were characterized by MS, IR, 1H and 13C NMR 
spectra. The structure of compound 2 was in accord with its spectroscopic data. The IR 
spectrum of compound 2 showed the principal absorption band at 1740 cm–1, indicating 
the presence of a carbonyl group (C=O) in the molecule, which confi rms the success of the 
alkylation reaction. In the 1H NMR spectrum, the characteristic ester protons appeared as 
a triplet at d 1.15 ppm and a quartet at d 4.02–4.05 ppm. The other methylene groups were 
observed as quintets ranging from d 1.95–1.98 ppm, triplets at d 2.41 ppm and triplets at d 
3.16 ppm, according to CH2CH2CH2, CH2CO and SCH2, respectively. All aromatic protons 
were observed at their usual chemical shi s with d 7.15–7.45 ppm. In the 13C NMR spec-
trum, one methyl carbon, was observed at d 14.09 ppm and the carbons of the four methy-
lene groups at d 24.61, 31.72, 32.22 and 59.88 ppm, respectively (see Table II). All aromatic 
carbons of the three phenyl groups and C=N gave signals between d 126.19–142.35 ppm. In 
addition, the carbon of the carbonyl group appeared at d 172.38 ppm.
The IR spectrum of acid hydrazide 3 showed absorption bands at 3256–3380 cm–1 cor-
responding to the NH and NH2 groups of the acid hydrazide, which confi rms the success 
of the hydrazinolysis reaction. The 1H NMR spectrum of 3 showed a quintet around d 
1.91–1.96 ppm due to the methylene group CH2CH2CH2. The remaining methylene groups 
of CH2CO and SCH2 showed triplets at d 2.14 and 3.14 ppm, respectively. In addition, NH2 
and NH groups were assigned to two singlets appearing at d 4.16 and 9.00 ppm, respec-
tively. The structure of 3 was also illustrated from its 13C NMR spectrum, which showed 
three carbons of the methylene groups at d 25.33, 32.01 and 32.25 ppm, while the remaining 
aromatic carbons and C=N appeared in the chemical shi  range of d 126.22–142.51 ppm. 
The carbon of the carbonyl group showed a signal at d 170.89 ppm.
The treatment of acid hydrazide 3 with carbon disulphide in ethanolic potassium 
hydroxide solution led to the formation of potassium dithiocarbazinate salt. Its treatment 
with hydrazine hydrate under refl ux furnished the desired 4-amino-5-[(1,4,5-triphenyl-
imidazol-2-yl)thiopropyl]-2H-1,2,4-triazole-3-thione (4) in 88 % yield (Scheme 1). IR spec-
trum of compound 4 exhibited N–H bands in the region 3240–3367 cm–1. The absorption 
bands at 1643 and 1290 cm–1 are due to the presence of C=N and C=S stretchings of the 
triazole ring system, respectively. The appearance of signals approximately at 5.76 ppm 
(NH2) and 14.40 ppm (NH), integrating two and one protons, respectively, in the 1H NMR 
spectra of compound 4 confi rmed the conversion of 3 into the corresponding aminotri-
azole 4. Aromatic protons were observed at 7.22–7.46 ppm. These groups were observed at 
126.80–163.38 ppm in the 13C NMR spectrum.
On the other hand, the reaction of the same hydrazide 3 with alkyl/aryl isothiocyanate 
furnished the corresponding aryl/alkylthiosemicarbazide derivatives 5–7 (Scheme 1). 
Their structures were established on the basis of their spectral data, which indicated the 
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presence of the thiocarbonyl group (C=S) by the appearance of new absorption bands at 
1290–1303 cm–1 in IR spectra. Their 1H NMR spectra showed the disappearance of NH2 
protons. The CONH and NHCSNH protons were observed in the range of d 7.88–9.90 ppm, 
confi rming the formation of thiosemicarbazides. Their carbon signals were observed in a 
chemical shi  range of d 171.31–173.66 ppm.
Cyclodehydration of compounds 5–7 was performed in alkaline medium to give the 
corresponding 4-alkyl/aryl-5-[(1,4,5-triphenylimidazol-2-yl)thiopropyl]-2H-1,2,4-triazole-
3-thiones (8–10) in yields ranging 79–84 % (Scheme 1).
The structure of 1,2,4-triazoles 8–10 displayed IR, 1H NMR and 13C NMR spectra con-
sistent with the assigned structures. In their IR spectra, the absorption peak correspond-
ing to the C=N group was observed around 1642–1697 cm–1. In their 1H NMR spectra, the 
appearance of signals arising from the thiol group (SH) at d 13.52–13.74 ppm provided 
evidence for the formation of triazole ring. Another support for the structure of these 
compounds was the disappearance of resonances arising from –CONH and –NHCSNH- 
around d 7.88–9.90 ppm. The remaining protons were also observed in the expected re-
gions (see Table II).
Ring closure of acid thiosemicarbazides 5–7 in acidic medium is a well known meth-
od for the synthesis of 1,3,4-thiadiazoles (28). Thus, 5-[(1,4,5-triphenylimidazol-2-yl)
thiopropyl]-2-(N-alkyl/arylamino)-1,3,4-thiadiazoles 11–13 were obtained in 70–84 % yield 
via the treatment of the above acid thiosemicarbazides 5–7 with H2SO4, concentration 98 
%, at 0 oC. Their IR spectra showed the absence of C=O and C=S stretching bands around 
1663–1670 and 1290–1302 cm–1, respectively, observed in the IR spectra of the thiosemicar-
bazide derivatives 5–7. The exhibited chemical shi s obtained from their 1H NMR spectra 
were all supported by the proposed structures of these thiadiazoles. Thus, the disappear-
ance of CONH and NHCSNH signals and appearance of a sharp singlet at d 9.90–10.48 ppm 
of the NH group in the 1H NMR spectra of compounds 11–13 accounted for the thiadiazole 
ring formation and was reconfi rmed by the 13C NMR peak at d 164.02–168.75 due to C2 of 
thiadiazole (see Table II).
The acid hydrazide 3 was also condensed with various aromatic aldehydes in the 
presence of a catalytic amount of concentrated hydrochloric acid in refl uxing ethanol to 
aff ord a new series of Schiff  bases 14–18 (Scheme 1).
It was reported in the literature (29, 30) that compounds having azomethine linkage 
exhibit E/Z geometrical isomerism around –C=N double bond and can exist as cis/trans 
amide conformers (30). Moreover, hydrazones were proven exist in higher percentage in 
DMSO-d6 solution in the form of geometrical E isomer.
The structures of the Schiff  bases were in accord with their spectroscopic data. The IR 
spectra of compounds 14–17 showed the disappearance of the absorption bands of NH2 
groups and the appearance of strong absorption bands at 3254–3342 cm–1 a ributed to the 
NH. The 1H and 13C NMR spectra of hydrazones 14–18 clearly showed the disappearance 
of the NH2 group of hydrazide structure and appearance of additional signals in the aro-
matic region belonging to the aldehydic protons.
The 1H NMR spectra of compounds 14–18 revealed the presence of two sets of signals 
belonging to the SCH2 and CH2CO groups of cis and trans conformers at 2.30–2.78 and 
3.17–3.26 ppm, respectively, in a 0.4 to 0.6 ratio (Fig. 1). Moreover, the azomethine CH pro-
ton and the amidic NH proton for compounds 15–18 resonated as two sets of signals at 
8.10–8.90 and 11.30–11.77 ppm, respectively, with the same ratio. On the other hand, the 
appearance of these protons in the 1H NMR spectrum of compound 14 as two sets of four 
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singlets can be considered as a proof of the formation of the geometrical Z form in both cis 
and trans conformation. This can be explained by an intramolecular hydrogen bonding 
connecting the azomethine nitrogen and the OH group of the aldehyde side chain, fa-
voured by a stable six-member ring.
The formation of E and Z forms could be a ributed to diff erent steric rearrangements 
of hydrazone functionality in the geometric syn and anti isomers resulting from the hin-
dered rotation of azomethine linkage.
Further evidence can be found by comparing the 1H NMR spectra of hydrazide 3 with 
hydrazones 14–18; no conformational equilibrium, under the same experimental condi-
tions, was observed for hydrazide 3.
Therefore, the NMR spectra of compounds 14–18 recorded in DMSO-d6 solution re-
vealed that all compounds existed as E geometrical isomers, except compound 14 which 
exhibited both E/Z geometrical isomerisms. Moreover, the cis/trans conformers of E and Z 
isomers were also observed.
Biological activity
Antibacterial activity. – Ethyl(1,4,5-triphenylimidazol-2-yl)thiobutyrate (2) and its hy-

























































































































































































































































































Fig. 1. 1H NMR spectrum of Schiff  base 14.
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to the ampicillin reference and comparable activity against E. coli compared to gentamicin 
reference. Triazole 4, bearing amino and thiol groups, exhibited approximately equal anti-
microbial activity against all tested microorganisms except P. aeruginosa.
The antimicrobial activity of the series 5–7 divulged compound 5, comprising phenyl 
substitution at N-4 exhibited the highest inhibition, whereas compounds 6 and 7 with alkyl 
substitution showed lower activity loss of inhibition against E. coli for compound 7.
Evaluation of the antimicrobial activity of the synthesized 4-alkyl/aryl-5-[(1,4,5-triphe-
nylimidazol-2-yl)thiopropyl]-1,2,4-triazole-3-thiols 8–10 revealed that compounds were 
more eff ective against Gram positive bacteria. In particular, N-4 phenyl substituted tri-
azole 8 exhibited activity against tested Gram positive bacteria comparable to its ampicil-
lin reference and lower inhibition against E. coli against compared to gentamicin. In con-
trast, compound 10, comprising methyl substitution, displayed no activity against Gram 
negative organisms.
The mean values of inhibition zone diameters summarized in Table III show that 
compounds 11–13 possess congruent antibacterial activities against the growth of S. pneu-
monia, B. subtilis and E. coli  compared to the standards ampicillin and gentamicin. Further-
more, N-phenyl thiadiazole 11 exhibited the highest antibacterial activity against all tested 
microorganisms, which can be a ributed to the presence of the thiadiazole ring.
Among the synthesized Schiff  bases 14–18, compound 14, having 2-OH substitution 
on the phenyl ring, displayed the best antibacterial activity against S. pneumonia, B. subti-
lis and E. coli. However, compounds possessing unsubstituted and halosubstituted phenyl 
rings exhibited good to moderate activity.
Antifungal activity
In general, most of the tested compounds were found to possess signifi cant antifungal 
activity against all fungal strains except S. racemosum.
Compounds 2 and 3 exhibited lower antifungal activity against A. fumigatus, G. candi-
dum and C. albicans compared to amphotericin B. The conversion of hydrazide structure 3 
to 1,2,4-triazole functionalized with both thiol and amino groups caused congruent anti-
fungal activity against A. fumigatus, G. candidum and C. albicans compared to the standard. 
On the other hand, 1-[4-(1,4,5-triphenylimidazol-2-ylthio)butanoyl]-4-phenyl/ethylthiosemi-
carbazides (5, 6)   displayed remarkable antifungal activity, whereas their methyl analogue 
7 displayed no activity against any of the fungal strains.
Contrary to what was expected, the cyclization of compounds 5–7 to their corre-
sponding 1,2,4-triazoles (8–10) caused no enhancement of the antifungal activity. On the 
other hand, the antifungal activity of the 1,3,4-thiadiazoles 11–13 revealed that all the 
tested compounds showed signifi cant inhibition; compound 11 having phenyl substitution 
exhibited the highest activity. Thiadiazoles 12 and 13 showed comparatively lower activ-
ity against A. fumigatus, G. candidum and C. albicans compared to the standard.
In the studied Schiff  bases series, 4-[(1,4,5-triphenylimidazol-2-yl)thio]-N’-(2-hydro xy-
benzylidene)-butanehydrazide (14) exhibited the highest antifungal activity against all 
fungal strains compared to amphotericin B.
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CONCLUSIONS
In conclusion, a series of novel imidazole compounds bearing 1,2,4-triazole, 1,3,4-thi-
adiazole or Schiff  base moieties were synthesized successfully via multistep synthesis. All 
the new compounds were fully spectroscopically characterized. The title compounds were 
synthesized as new compounds with antimicrobial activity in vitro.
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